Hassell Wealth Management’s Vanguard Intermediate-Term Corporate Bond ETF VCIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.3M Sell
272,231
-31,499
-10% -$2.6M 6.83% 5
2026
Q1
$25.1M Sell
303,730
-12,966
-4% -$1.08M 8.43% 5
2025
Q4
$26.5M Buy
316,696
+7,928
+3% +$666K 8.87% 3
2025
Q3
$26M Buy
308,768
+13,407
+5% +$1.12M 9.01% 3
2025
Q2
$24.4M Buy
295,361
+19,723
+7% +$1.6M 8.91% 3
2025
Q1
$22.1M Buy
275,638
+17,533
+7% +$1.42M 9.42% 3
2024
Q4
$20.9M Buy
258,105
+19,908
+8% +$1.63M 8.41% 3
2024
Q3
$19.4M Buy
238,197
+12,411
+5% +$1.02M 8.12% 4
2024
Q2
$18.3M Buy
+225,786
New +$17.9M 8.22% 4

Other funds holding VCIT

Hassell Wealth Management's VCIT Position: Q2 2026 in Review

Hassell Wealth Management reduced its Vanguard Intermediate-Term Corporate Bond ETF (VCIT) stake by 10% in Q2 2026, selling an estimated $2.6M and leaving 272,231 shares worth $22.3M. The position accounts for 6.83% of the portfolio, ranked #5.

Hassell Wealth Management first reported a position in VCIT in Q2 2024 and has held it in 9 quarters since. The position peaked at $26.5M in Q4 2025. 440 funds tracked by Wall St. Rank hold VCIT as of Q2 2026.

  • Hassell Wealth Management held 272,231 shares of Vanguard Intermediate-Term Corporate Bond ETF worth $22.3M as of Q2 2026.
  • Hassell Wealth Management sold 31,499 Vanguard Intermediate-Term Corporate Bond ETF shares in Q2 2026, an estimated $2.6M.
  • Vanguard Intermediate-Term Corporate Bond ETF made up 6.83% of Hassell Wealth Management's portfolio in Q2 2026, its #5 holding.
  • Hassell Wealth Management first reported a position in Vanguard Intermediate-Term Corporate Bond ETF in Q2 2024 and has held it in 9 quarters since.
  • Hassell Wealth Management's Vanguard Intermediate-Term Corporate Bond ETF position peaked at $26.5M in Q4 2025.
  • 440 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Corporate Bond ETF as of Q2 2026.

Based on Hassell Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.